Human cytomegalovirus-associated periodontitis in renal transplant patients

By Nowzari H.   Jorgensen M.G.   Aswad S.   Khan N.   Osorio E.   Safarian A.   Shidban H.   Munroe S.  

Transplantation Proceedings, Vol. 35, Iss. 8, 2003-12 ,pp. : 2949-2952

Elsevier

Access to resources Recommend Favorite

Effective strategies to prevent cytomegalovirus disease after renal transplantation

By Chapman J.R.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1508-1509

Elsevier

Access to resources Recommend Favorite

Polymerase Chain Reaction-Triggered Preemptive or Deferred Therapy to Control Cytomegalovirus-Associated Morbidity and Costs in Renal Transplant Patients

By Brennan D.C.   Garlock K.A.   Lippmann B.J.   Buller R.S.   Gaudreault-Keener M.   Lowell J.A.   Miller S.B.   Shenoy S.   Howard T.K.   Storch G.A.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 809-811

Elsevier

Access to resources Recommend Favorite

The history of cytomegalovirus and its diseases

By Ho Monto  

Medical Microbiology and Immunology, Vol. 197, Iss. 2, 2008-06 ,pp. : 65-73

Springer Publishing Company

Access to resources Recommend Favorite

Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets

By de Cassan Simone C   Draper Simon J  

Expert Review of Vaccines, Vol. 12, Iss. 4, 2013-04 ,pp. : 365-378

Informa Healthcare

Access to resources Recommend Favorite